CVA Family Office’s EPAM Systems EPAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.73K Sell
47
-6
-11% -$634 ﹤0.01% 1365
2026
Q1
$7.18K Sell
53
-256
-83% -$43.8K ﹤0.01% 1105
2025
Q4
$63.3K Buy
309
+62
+25% +$11.1K 0.01% 515
2025
Q3
$37.2K Buy
247
+242
+4,840% +$39.7K ﹤0.01% 593
2025
Q2
$884 Sell
5
-55
-92% -$9.19K ﹤0.01% 1111
2025
Q1
$10.1K Buy
60
+38
+173% +$8.38K ﹤0.01% 792
2024
Q4
$5.14K Buy
22
+5
+29% +$1.11K ﹤0.01% 877
2024
Q3
$3.38K Buy
17
+5
+42% +$1K ﹤0.01% 905
2024
Q2
$2.26K Buy
12
+7
+140% +$1.49K ﹤0.01% 933
2024
Q1
$1.38K Hold
5
– – ﹤0.01% 966
2023
Q4
$1.49K Buy
+5
New +$1.27K ﹤0.01% 937
2023
Q2
– Sell
-10
Closed -$2.99K – 1027
2023
Q1
$2.99K Sell
10
-25
-71% -$8.05K ﹤0.01% 829
2022
Q4
$11.5K Sell
35
-15
-30% -$5.1K ﹤0.01% 642
2022
Q3
$18K Buy
50
+25
+100% +$9.56K ﹤0.01% 542
2022
Q2
$7K Buy
25
+20
+400% +$6.11K ﹤0.01% 697
2022
Q1
$1K Buy
+5
New +$1.96K ﹤0.01% 916

Other funds holding EPAM

CVA Family Office's EPAM Position: Q2 2026 in Review

CVA Family Office reduced its EPAM Systems (EPAM) stake by 11% in Q2 2026, selling an estimated $634 and leaving 47 shares worth $3.73K. The position accounts for ﹤0.01% of the portfolio, ranked #1365.

CVA Family Office first reported a position in EPAM in Q1 2022 and has held it in 16 quarters since. The position peaked at $63.3K in Q4 2025. 440 funds tracked by Wall St. Rank hold EPAM as of Q2 2026.

  • CVA Family Office held 47 shares of EPAM Systems worth $3.73K as of Q2 2026.
  • CVA Family Office sold 6 EPAM Systems shares in Q2 2026, an estimated $634.
  • EPAM Systems made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1365 holding.
  • CVA Family Office first reported a position in EPAM Systems in Q1 2022 and has held it in 16 quarters since.
  • CVA Family Office's EPAM Systems position peaked at $63.3K in Q4 2025.
  • 440 funds tracked by Wall St. Rank held EPAM Systems as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.